Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
TVTX | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Officer | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,085 | 47,614 | Aug 17, 2021, 07:39 PM | |
TVTX | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Officer | Jul 28, 2021 | Sale | $13.81 | 1,250 | 17,263 | 44,521 | Jul 29, 2021, 04:09 PM | |
TVTX | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Officer | Feb 05, 2021 | Sale | $31.41 | 1,125 | 35,336 | 47,469 | Feb 09, 2021, 04:32 PM | |
TVTX | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Officer | Feb 08, 2021 | Sale | $31.58 | 1,125 | 35,527 | 46,344 | Feb 09, 2021, 04:32 PM | |
TVTX | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Officer | Feb 03, 2021 | Sale | $28.91 | 1,813 | 52,414 | 44,657 | Feb 03, 2021, 09:33 PM | |
TVTX | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Officer | Feb 02, 2021 | Sale | $30.75 | 1,813 | 55,750 | 46,470 | Feb 02, 2021, 09:31 PM | |
RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Officer | Sep 23, 2020 | Sale | $18.48 | 750 | 13,860 | 27,555 | Sep 23, 2020, 08:00 PM | |
RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Officer | Sep 22, 2020 | Sale | $18.59 | 750 | 13,943 | 28,305 | Sep 22, 2020, 09:20 PM | |
RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Officer | Jul 28, 2020 | Sale | $20.49 | 870 | 17,826 | 26,055 | Jul 30, 2020, 07:48 PM | |
RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Officer | May 12, 2020 | Sale | $16.98 | 527 | 8,951 | 26,728 | May 13, 2020, 09:00 PM | |
RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Officer | Mar 05, 2020 | Sale | $15.36 | 1,790 | 27,487 | 27,255 | Mar 09, 2020, 09:05 PM | |
RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Officer | Jul 30, 2019 | Sale | $19.82 | 1,250 | 24,775 | 14,750 | Jul 31, 2019, 09:15 PM | |
RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Officer | Jul 31, 2019 | Sale | $20.07 | 1,250 | 25,087 | 13,500 | Jul 31, 2019, 09:15 PM |